Literature DB >> 26341268

Skeletal muscle perfusion and stem cell delivery in muscle disorders using intra-femoral artery canulation in mice.

Nadine Matthias1, Samuel D Hunt1, Jianbo Wu1, Radbod Darabi2.   

Abstract

Muscular dystrophies are among major inherited muscle disorders characterized by progressive muscle damage and fibrosis with no definitive cure. Recently, gene or cell based therapies have been developed to restore the missing gene expression or replace the damaged tissues. In order to test the efficiency of these therapies in mice models of muscular dystrophies, the arterial route of delivery is very advantageous as it provides uniform muscle exposure to the therapeutic agents or cells. Although there are few reports of arterial delivery of the therapeutic agents or cells in mice, there is no in-depth description and evaluation of its efficacy in perfusion of downstream muscles. This study is aimed to develop a practical method for intra-femoral artery perfusion in mice and to evaluate perfusion efficiency using near-infrared-fluorescence (NIRF) imaging as well as histology following stem cell delivery. Our results provide a practical guide to perform this delicate method in mice. By using a sensitive fluorescent dye, different muscle groups of the hindlimb have been evaluated for proper perfusion. As the final step, we have validated the efficiency of arterial cell delivery into muscles using human iPS-derived myogenic cells in an immunodeficient mouse model for Duchenne muscular dystrophy (NSG-mdx(4cv)).
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  IA delivery; Intra-femoral artery perfusion; Muscular dystrophies; Skeletal muscle; Stem cell therapy

Mesh:

Substances:

Year:  2015        PMID: 26341268     DOI: 10.1016/j.yexcr.2015.08.018

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  4 in total

Review 1.  Muscle Stem/Progenitor Cells and Mesenchymal Stem Cells of Bone Marrow Origin for Skeletal Muscle Regeneration in Muscular Dystrophies.

Authors:  Aleksandra Klimczak; Urszula Kozlowska; Maciej Kurpisz
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2018-03-13       Impact factor: 4.291

2.  CCR2 improves homing and engraftment of adipose-derived stem cells in dystrophic mice.

Authors:  Liang Wang; Huan Li; Jinfu Lin; Ruojie He; Menglong Chen; Yu Zhang; Ziyu Liao; Cheng Zhang
Journal:  Stem Cell Res Ther       Date:  2021-01-07       Impact factor: 6.832

3.  Assessing and enhancing migration of human myogenic progenitors using directed iPS cell differentiation and advanced tissue modelling.

Authors:  SungWoo Choi; Giulia Ferrari; Louise A Moyle; Kirsty Mackinlay; Naira Naouar; Salma Jalal; Sara Benedetti; Christine Wells; Francesco Muntoni; Francesco Saverio Tedesco
Journal:  EMBO Mol Med       Date:  2022-09-26       Impact factor: 14.260

Review 4.  iPSCs as a Platform for Disease Modeling, Drug Screening, and Personalized Therapy in Muscular Dystrophies.

Authors:  Jose L Ortiz-Vitali; Radbod Darabi
Journal:  Cells       Date:  2019-01-03       Impact factor: 6.600

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.